Andrew Jones considers a recent cohort study that looks into the associations between maternal smoking during pregnancy and severe mental illness in offspring.
[read the full story...]
Andrew Jones considers a recent cohort study that looks into the associations between maternal smoking during pregnancy and severe mental illness in offspring.
[read the full story...]
Jess Bone on a systematic review of longitudinal studies, which explores the different trajectories of depressive symptoms in children and adolescents, and the factors that might help predict or protect young people.
[read the full story...]
Jasmin Wertz summarises a recent article that explores how fathers, fathering, parenting styles and dads’ mental health may shape the development of child psychopathology.
[read the full story...]
Francesca Solmi summarises a new systematic review of stigma and eating disorders, and asks if it’s time to move beyond socio-cultural explanations of risk.
[read the full story...]
Carla McEnery appraises a new study that asks: are social and communication difficulties a risk factor for the development of social anxiety?
[read the full story...]
Joe Barnby considers the findings of a recent meta-analysis of cannabis use and symptoms severity in individuals at ultra-high risk for psychosis.
[read the full story...]
Emily Stapley summarises a recent 4-year longitudinal study of the antecedents of new-onset major depressive disorder in children and adolescents at high familial risk.
[read the full story...]
Michelle Moulds publishes her debut blog on a recent randomised controlled trial about the prevention of anxiety disorders and depression by targeting excessive worry, rumination and repetitive negative thinking in young adults.
[read the full story...]
Marcus Munafo looks at a complex and sophisticated series of experiments that provide further insight into the relationships between genetic risk, cigarette smoking and schizophrenia.
[read the full story...]
Harry Sumnall, Ian Hamilton and Mark Monaghan provide an overview of Novel Psychoactive Substances (NPS) aimed at health professionals and others who work with people who use these new psychoactive substances.
[read the full story...]